International Centre for Genetic Engineering and Biotechnology (ICGEB) at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

International Centre for Genetic Engineering and Biotechnology (ICGEB) brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on inherited metabolic liver disease. Topics include mRNA in lipid nanoparticles combined with gene targeting for severe ornithine transcarbamylase deficiency and a way to quantify liver cell turnover so treatment can be timed.

OrganizationESGCT 2026 Attendance
icgeb.org
Universities & institutes
Intergovernmental research organization with laboratories in Trieste, New Delhi and Cape Town.
Poster
Wed Oct 28
1:30pm–3:30pm
Combination of mRNA-LNP and gene targeting approaches as a potential cure for early-onset, severe ornithine transcarbamylase deficiency
Metabolic diseases
Poster
Thu Oct 29
2:00pm–4:00pm
HepCycle-Track Quantifies Hepatocyte Proliferation to Define Therapeutic Timing as a Precision Parameter for Gene Therapy and Genome Editing
Metabolic diseases

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from International Centre for Genetic Engineering and Biotechnology (ICGEB)

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction